Peter E Lobie Selected Research

Large Neutral Amino Acid-Transporter 1

1/2018

GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter E Lobie Research Topics

Disease

63	Breast Neoplasms (Breast Cancer) 02/2024 - 07/2002
63	Neoplasms (Cancer) 01/2024 - 10/2006
40	Carcinoma (Carcinomatosis) 11/2023 - 07/2002
21	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2011
9	Endometrial Neoplasms (Endometrial Cancer) 09/2017 - 08/2008
8	Hepatocellular Carcinoma (Hepatoma) 07/2017 - 07/2011
5	Triple Negative Breast Neoplasms 01/2024 - 01/2015
4	Disease Progression 09/2022 - 06/2014
4	Carcinogenesis 01/2021 - 08/2015
4	Lymphatic Metastasis 01/2019 - 10/2011
2	Adenocarcinoma 02/2024 - 05/2015
2	Ovarian Epithelial Carcinoma 02/2022 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 12/2020
2	Adenocarcinoma of Lung 11/2019 - 05/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2019 - 05/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 05/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2023

Drug/Important Bio-Agent (IBA)

20	Estrogen ReceptorsIBA 11/2023 - 12/2010
18	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2002
18	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2024 - 07/2002
13	MicroRNAs (MicroRNA)IBA 11/2022 - 07/2011
13	Trefoil Factor-3IBA 09/2022 - 12/2010
12	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2011
11	Tamoxifen FDA LinkGeneric 11/2023 - 12/2010
11	Messenger RNA (mRNA)IBA 01/2021 - 01/2007
9	Estrogens (Estrogen)FDA Link 01/2023 - 12/2010
8	LigandsIBA 01/2022 - 06/2010
8	Small Interfering RNA (siRNA)IBA 05/2015 - 06/2005
6	Growth Hormone (Somatotropin)IBA 01/2024 - 10/2006
5	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 02/2003
5	Long Noncoding RNAIBA 02/2024 - 12/2017
5	Phosphotransferases (Kinase)IBA 01/2024 - 05/2005
5	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2023 - 07/2011
5	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 06/2010
5	Hormones (Hormone)IBA 01/2018 - 10/2006
5	Cadherins (E-Cadherin)IBA 05/2016 - 03/2006
4	ProlactinIBA 01/2017 - 10/2011
4	Transcription Factors (Transcription Factor)IBA 08/2015 - 06/2013
3	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2022 - 01/2011
3	4-nitrophenethyl bromide (NPB)IBA 10/2021 - 10/2018
3	Epidermal Growth Factor (EGF)IBA 06/2013 - 10/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 03/2009
3	Fibronectins (Fibronectin)IBA 01/2012 - 10/2004
2	Tyrosine (L-Tyrosine)FDA Link 01/2024 - 08/2015
2	AntioxidantsIBA 01/2024 - 05/2005
2	imidazopyridineIBA 12/2023 - 01/2023
2	PyrimidinesIBA 10/2023 - 01/2018
2	pyrimidineIBA 10/2023 - 04/2023
2	NF-kappa B (NF-kB)IBA 10/2023 - 05/2016
2	ThiouracilIBA 07/2023 - 04/2022
2	TriazolesIBA 07/2023 - 06/2023
2	OxadiazolesIBA 06/2023 - 01/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2023 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 11/2007
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 01/2015
2	RNA IsoformsIBA 11/2022 - 01/2017
2	Protein Isoforms (Isoforms)IBA 11/2022 - 09/2010
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 12/2010
2	PlatinumIBA 01/2022 - 12/2020
2	Estrogen Receptor alphaIBA 01/2022 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2017
2	3' Untranslated Regions (3' UTR)IBA 01/2021 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 12/2019
2	Caspase 3 (Caspase-3)IBA 10/2018 - 12/2014
2	ClaudinsIBA 11/2017 - 01/2011
2	Phenobarbital (Luminal)FDA Link 10/2017 - 09/2017
2	Trastuzumab (Herceptin)FDA Link 09/2017 - 06/2014
2	matrigelIBA 06/2017 - 01/2012
2	azaspiraneIBA 09/2016 - 12/2014
2	AgarIBA 08/2015 - 02/2003
2	Complementary DNA (cDNA)IBA 05/2015 - 06/2014
2	Janus KinasesIBA 12/2014 - 01/2005
2	Prolactin Receptors (Prolactin Receptor)IBA 12/2012 - 04/2011
2	VimentinIBA 01/2012 - 10/2004
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2024
1	HydrazonesIBA 01/2024
1	tyrosine receptor (receptor, tyrosine)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Docetaxel (Taxotere)FDA Link 12/2023
1	taxaneIBA 11/2023
1	PiperazineIBA 10/2023
1	Histone Deacetylase InhibitorsIBA 07/2023
1	IsoxazolesIBA 07/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2023
1	Sulfhydryl Compounds (Thiols)IBA 06/2023
1	coumarinIBA 04/2023
1	human ERBB2 proteinIBA 04/2023
1	EnzymesIBA 01/2023
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2023

Therapy/Procedure

22	Therapeutics 02/2024 - 01/2011
7	Drug Therapy (Chemotherapy) 05/2023 - 08/2011
4	Precision Medicine 02/2022 - 12/2020
1	Immunotherapy 01/2024